Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Darbepoetin alfa
Locations
1
Hong Kong
Division of Nephrology, Department of Medicine, Queen Mary Hospital
Hong Kong, Hong Kong
Start Date
November 1, 2015
Primary Completion Date
November 1, 2017
Completion Date
November 1, 2017
Last Updated
June 4, 2018
NCT05012111
NCT03520647
NCT05447442
NCT06287268
NCT04645199
NCT03050268
Lead Sponsor
The University of Hong Kong
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions